Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lineage Cell Therapeutics (LCTX) Debt Ratio (2016 - 2021)

Lineage Cell Therapeutics (LCTX) has 6 years of Debt Ratio data on record, last reported at 0.0 in Q1 2021.

  • For Q1 2021, Debt Ratio changed N/A year-over-year to 0.0; the TTM value through Mar 2021 reached 0.0, changed N/A, while the annual FY2020 figure was 0.0, N/A changed from the prior year.
  • Debt Ratio reached 0.0 in Q1 2021 per LCTX's latest filing, down from 0.0 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.01 in Q3 2020 and bottomed at 0.0 in Q4 2017.
  • Average Debt Ratio over 3 years is 0.0, with a median of 0.0 recorded in 2021.
  • The widest YoY moves for Debt Ratio: up 70.37% in 2017, down 87.66% in 2017.
  • A 3-year view of Debt Ratio shows it stood at 0.0 in 2017, then skyrocketed by 4562.96% to 0.0 in 2020, then fell by 15.62% to 0.0 in 2021.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.0 in Q1 2021, 0.0 in Q4 2020, and 0.01 in Q3 2020.